Write to Us

    Your Name (required)

    Your Email (required)


    Your Message

    Contact Us

    Matrix II, unit 1.10
    Science Park 400
    1098 XH Amsterdam
    The Netherlands


    Phone No: +31 20 7400 778

    Follow Us on Twitter

    June 20, 2016

    MAFEIP follow up: Panaxea joins European Innovation Partnership on Active and Healthy Ageing Action Groups

    Following an earlier involvement with the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA), Panaxea is now a partner for the 2016-2018 period. EIP on AHA EIP on AHA is a policy initiative that aims to share and scale up innovative solutions to improve active and healthy ageing […]
    June 20, 2016

    Further research for predictive biomarkers

    Lotte Steuten worked along with Anna Miquel-Cases, Valesca Retèl, and Wim van Harten on a paper on decision about design and priority of studies of emerging predictive biomarkers of high-dose alkylating chemotherapy (HDAC) in triple-negative breast cancer (TNBC). The paper was published in Value in Health. The information was gathered by a value-of-information […]
    June 17, 2016

    Management and performance features of cancer centers in Europe

    Isabelle is a co-author on a paper in which the performance features of cancer centers in the European Union are identified. The findings showed that public, comprehensive cancer centers with at least two of the three other explanatory conditions (dedication to R&D, annual budget, or size) have an association with high […]
    June 13, 2016

    New VOKA white paper: Value based care innovation and logistics

    Panaxea contributed to the new Voka white paper: Value based care innovation and logistics. This white paper shares the vision of a diverse group of stakeholders on the future of value based decisions in health care. The full white paper can be found here (Dutch only). Voka Health Community brings entrepreneurs, health […]
    June 8, 2016

    Implications for policy and Health Technology Assessment when enabling equal access to molecular diagnostics

    Lotte Steuten is co-author on a new paper regarding Molecular Diagnostics, published by Public Health Genomics. The paper, with Juliette Plun-Favreau as first author, discusses the necessary evolutions in policy and health technology assessment to ensure that patients can have equal access to appropriate molecular diagnostics. The article considers the perspectives of different stakeholders (patients, health […]
    June 6, 2016
    Healthcare innovations

    From re-search to pro-search: P-value

    Innovations in healthcare transform the way healthcare gets delivered and the lives of people. Healthcare is getting person-centred and people are getting proactive. Do you recognize a pattern here? I’m talking about P-value: person-centered and proactive. But how does this translate into the evaluation of healthcare innovations and the assessment […]
    June 1, 2016

    Organizational innovations to accelerate technology transfer and translational research — Do they work?

    Recently, a paper by Lotte Steuten was published in ‘OMICS: A Journal of Integrative Biology’. This paper is a result of a Panaxea project, to promote the need for institutional innovation to cultivate translational research. According to Dr Steuten: Lessons learned from this study may inform future innovation impact assessments […]
    May 30, 2016

    Senior Consultant Vacancy

    Panaxea is seeking to find an experienced and passionate senior consultant with an interest in business development to expand our team. The generation of new clients, the ongoing relationship management with existing clients and the successful management of projects are essential to the growth, security and prosperity of our company. […]
    May 26, 2016
    Our Future Health

    Bert Vrijhoef at Our Future Health

    Our Future Health started today with presentations from the Dutch Minister of Health, Welfare and Sport Edith Schippers, and Ex-European Commissioner Neelie Kroes. Tomorrow (27th of May) is the day that Bert will pitch his ideas! He will use this opportunity to pitch his ideas on the innovation of research […]